VERVE-102: The One-Time Treatment for Bad Cholesterol

A groundbreaking gene editing treatment called VERVE-102 is here to tackle bad cholesterol! This one-time wonder has shown promising results in cutting LDL levels for those at high risk of heart disease. Researchers are buzzing with excitement, hoping it could mean fewer meds and more heart-healthy lives. Stay tuned for more updates on this revolutionary approach!

Quick rundown

1.VERVE-102 shows promise in lowering bad cholesterol permanently.

2.Base editing targets PCSK9 gene to reduce LDL levels.

3.Phase 1 trial shows significant cholesterol reduction.

4.Some participants had mild infusion reactions.

5.Future trials could revolutionize heart disease prevention.

China's GLP-1 Pills: The Game-Changer for India's Obesity Market
China's GLP-1 Pills: The Game-Changer for India's Obesity Market
Hold onto your lab coats, folks! China’s weight-loss pills are crashing the Indian pharma party, and they’re bringing the glitz! With Innovent and Hengrui leading the charge, these GLP-1 marvels offer a no-needle approach to shedding pounds. Forget the old-school injections; it’s all about popping a pill and saying goodbye to those extra snacks. Obesity, meet your match!
11:40 am on Monday, 27 April, 2026

Series

View All

Cricket